TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

TCRX: Clinical trials review - updated

1. NCT05230186 - A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Last update - February 8/22
https://classic.clinicaltrials.gov/ct2/history/NCT05230186?A=1&B=2&C=merged#StudyPageTop

2. NCT05473910 - Study of TSC-100 and TSC-101 in AML, ALL and MDS Patients Undergoing Haploidentical Donor Transplantation
Last update - Deccember 6/23
https://classic.clinicaltrials.gov/ct2/history/NCT05473910?A=1&B=10&C=merged#StudyPageTop

3. NCT05812027 - A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Last updated - January 10/24
https://classic.clinicaltrials.gov/ct2/history/NCT05812027?A=1&B=11&C=merged#StudyPageTop

4. NCT05973487 - A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid
Tumors
Last updated - January 9/24
https://classic.clinicaltrials.gov/ct2/history/NCT05973487?A=1&B=5&C=merged#StudyPageTop